Header image

Session 2

Wednesday, April 28, 2021
10:00 - 11:00

Speaker

Agenda Item Image
Dr Alex Miras
Imperial College London

Evidence that anti obesity medications (aom) can be used to place diabetes into remission

10:00 - 10:20

Biography

Alex Miras is a Senior Lecturer and Consultant in Endocrinology and Obesity Medicine at Imperial College London. His clinical and research work focus solely on Obesity. He has contributed to the clinical management and research in Obesity over the last 10 years, through his work at a high throughput Obesity Centre. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices and obesity surgery. He has delivered invited lectures at national and international meetings, contributed to national clinical guideline development, published his research in high impact factor journals and disseminated his findings to the lay public. He is an active member of the All-Party Parliamentary Group on Obesity that seeks to change policy at the highest level. He is a SCOPE (Specialist Certification of Obesity Professional Education) National Fellow for the UK and associate editor for Surgery for obesity and associated disorders and Obesity Surgery.
Agenda Item Image
Dr Karl Neff
Consultant Endocrinologist, Ireland East Hospital Group

How can anti obesity medications (aom) be implemented in practice

10:20 - 10:40

Biography

Dr Neff is a Consultant Endocrinologist and Obesity Physician, with a special interest in the use of bariatric and metabolic surgery as a treatment for diabetes and the complications of diabetes. Following graduation from the National University of Ireland in Galway, Dr Neff completed Higher Specialist Training in Endocrinology and Diabetes in Ireland, and wrote his PhD thesis on the effect of bariatric and metabolic surgery on the complications of diabetes in University College Dublin. In 2016 he moved to King’s College Hospital in London. During his time in King’s, he took a lead role in the Obesity service, working with the expert multidisciplinary team in King’s to optimise pre-operative assessment and peri-operative management of diabetes. In 2019, he returned to Dublin to take up a position in the Ireland East Hospital Group and is now a Principal Investigator in the Diabetes Complications Research Centre at the Conway Institute of University College Dublin. Dr Neff has published widely on the topic of obesity and metabolic disease, and has contributed to several textbooks on bariatric and diabetes care. With colleagues across Europe, he co-authored the first international recommendations on prenatal and antenatal care in bariatric surgery recipients.

Chair

Agenda Item Image
Chris Collins
National University Of Ireland, Galway


Host

Francois Tessier
Abbey Conference & Events

loading